Last reviewed · How we verify

Placebo capsule of DLBS3233

Dexa Medica Group · Phase 3 active Small molecule

Placebo capsule of DLBS3233 is a Small molecule drug developed by Dexa Medica Group. It is currently in Phase 3 development. Also known as: Placebo capsule of Inlacin, Placebo of Inlacin.

This is a placebo capsule used as a control in clinical trials of DLBS3233.

At a glance

Generic namePlacebo capsule of DLBS3233
Also known asPlacebo capsule of Inlacin, Placebo of Inlacin
SponsorDexa Medica Group
ModalitySmall molecule
PhasePhase 3

Mechanism of action

As a placebo, this capsule contains no active pharmaceutical ingredient and serves as a comparator arm in phase 3 trials. It is designed to be indistinguishable from the active DLBS3233 formulation to maintain blinding in randomized controlled studies.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Placebo capsule of DLBS3233

What is Placebo capsule of DLBS3233?

Placebo capsule of DLBS3233 is a Small molecule drug developed by Dexa Medica Group.

How does Placebo capsule of DLBS3233 work?

This is a placebo capsule used as a control in clinical trials of DLBS3233.

Who makes Placebo capsule of DLBS3233?

Placebo capsule of DLBS3233 is developed by Dexa Medica Group (see full Dexa Medica Group pipeline at /company/dexa-medica-group).

Is Placebo capsule of DLBS3233 also known as anything else?

Placebo capsule of DLBS3233 is also known as Placebo capsule of Inlacin, Placebo of Inlacin.

What development phase is Placebo capsule of DLBS3233 in?

Placebo capsule of DLBS3233 is in Phase 3.

Related